This is to inform you that the US FDA conducted a Good Manufacturing Practices (GMP) Inspection of Piramal Pharma Limited’s Digwal facility from 27th March, 2023 to 31st March, 2023. The inspection was completed successfully with Zero Form – 483 observations. The Company remains committed to maintain the highest standards of compliance.
| Subscribe To Our Free Newsletter |
